Short duration combination chemotherapy in the treatment of small cell lung cancer.
Ninety five patients (57 with limited disease and 38 with extensive disease) with previously untreated small cell lung cancer were entered into a study of short duration combination chemotherapy with intravenous cyclophosphamide (750 mg/m2) on day 1, adriamycin (40 mg/m2) on day 1, and etoposide VP-...
Guardat en:
| Publicat a: | Thorax |
|---|---|
| Autors principals: | , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMJ Publishing Group
1986
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC460432/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3024351/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/thx.41.9.688 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|